Technical
Channels

Drug Delivery

QA/QC and Compliance

Pharmaceutical Processing and Packaging

BD announces Q2 results


Dated: 5/8/2008

Becton, Dickinson and Company has reported record quarterly revenues of $1.747 billion for the second fiscal quarter ended March 31, 2008, representing an increase of 11% over the prior year period.

This quarter's revenue growth rate reflects the favorable impact on all segments from foreign currency translation, which overall is estimated to account for 5% points of the increase in quarterly revenues.

Reported diluted earnings per share from continuing operations of $1.09 for the second quarter increased by 18% over diluted earnings per share from continuing operations of 92 cents for the second fiscal quarter of 2007.

For the six-month period ending March 31, 2008, reported diluted earnings per share from continuing operations were $2.16.

For the six-month period ending March 31, 2007, reported diluted earnings per share from continuing operations were $1.44.

  Related Industry Links
 
Pharmaceutical Society of Hong Kong (China)
Organization of Pharmaceutical Producers of India
 
 

Reed Business Information Asia | EM Asia | EM Asia (China) | Control Engineering Asia | Asia Food Journal
Drug Discovery & Development | Genomics & Proteomics | Pharmaceutical Processing | R&D | BioScience Technology

 
ABOUT PHARMA ASIA | FREE SUBSCRIPTION | CONTACT US
   
 
© 2008 Reed Business Information, a division of Reed Elsevier Inc. All rights reserved.
Use of this web site is subject to its Terms and Conditions of Use. View our Privacy Policy.